Showing results (131-140 of 194) with videos related to

Sort By:
Pageof 20
The Journal of Infectious Diseases|November 25, 2025
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure Proximal Design but Requires Far Fewer Blood SamplesDean Follmann, Lauren Dang, Eric Chu, et al.
Nature Communications|October 14, 2025
A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19Rhiannon Edge, Sam Matthews, Bahar Ahani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2017
Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, UgandaJessica L Prodger, Jun Lai, Steven J Reynolds, et al.
The Journal of Infectious Diseases|March 15, 2011
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trialJulie E Ledgerwood, Theodore C Pierson, Sarah A Hubka, et al.
Plos Pathogens|June 5, 2010
Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite controlAdam R Hersperger, Florencia Pereyra, Martha Nason, et al.
American Journal of Infection Control|March 3, 2019
Attributable mortality from extensively drug-resistant gram-negative infections using propensity-matched tracer antibiotic algorithmsSameer S Kadri, Jeffrey R Strich, Bruce J Swihart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2018
Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS)Scott R Evans, Dean Follmann, Ying Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|October 6, 2021
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant SurgeLindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
Pageof 20